Adverse events1,628

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,628

Type	Event	Organ system	Group	Affected	At risk	Events
other	Deep vein thrombosis	Vascular disorders	Combination Therapy: Placebo + Chemotherapy	4	65	4
other	Deep vein thrombosis	Vascular disorders	Combination Therapy: Farletuzumab + Chemotherapy	3	64	3
other	Deep vein thrombosis	Vascular disorders	Monotherapy: Placebo	0	35	0
other	Deep vein thrombosis	Vascular disorders	Monotherapy: Farletuzumab	1	31	1
other	Cancer pain	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Combination Therapy: Placebo + Chemotherapy	2	65	2
other	Cancer pain	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Combination Therapy: Farletuzumab + Chemotherapy	1	64	1
other	Cancer pain	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Monotherapy: Placebo	2	35	3
other	Cancer pain	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Monotherapy: Farletuzumab	0	31	0
other	Asthenia	General disorders	Combination Therapy: Placebo + Chemotherapy	12	65	13
other	Asthenia	General disorders	Combination Therapy: Farletuzumab + Chemotherapy	22	64	32
other	Asthenia	General disorders	Monotherapy: Placebo	3	35	3
other	Asthenia	General disorders	Monotherapy: Farletuzumab	2	31	2
other	Fatigue	General disorders	Combination Therapy: Placebo + Chemotherapy	29	65	48
other	Fatigue	General disorders	Combination Therapy: Farletuzumab + Chemotherapy	24	64	29
other	Fatigue	General disorders	Monotherapy: Placebo	3	35	4
other	Fatigue	General disorders	Monotherapy: Farletuzumab	1	31	1
other	Pyrexia	General disorders	Combination Therapy: Placebo + Chemotherapy	6	65	8
other	Pyrexia	General disorders	Combination Therapy: Farletuzumab + Chemotherapy	9	64	15
other	Pyrexia	General disorders	Monotherapy: Placebo	1	35	1
other	Pyrexia	General disorders	Monotherapy: Farletuzumab	2	31	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01218516/events

API reference For AI assistants

Adverse events1,628

Sources 3

Read this list from software.